PMC:7306567 / 2576-2674 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7306567","sourcedb":"PMC","sourceid":"7306567","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7306567","text":" and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive aspergill","tracks":[{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T33","span":{"begin":17,"end":34},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T96288","span":{"begin":17,"end":34},"obj":"CHEBI:35705;CHEBI:35705"}],"attributes":[{"subj":"T33","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T96288","pred":"source","obj":"LitCovid-PMC-OGER-BB"}]},{"project":"2_test","denotations":[{"id":"32572532-25354514-47963394","span":{"begin":44,"end":45},"obj":"25354514"},{"id":"T48775","span":{"begin":44,"end":45},"obj":"25354514"}],"attributes":[{"subj":"32572532-25354514-47963394","pred":"source","obj":"2_test"},{"subj":"T48775","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PMC-OGER-BB","color":"#d5ec93","default":true},{"id":"2_test","color":"#e993ec"}]}]}}